LISA HAUT: Open Payments
NPI 1962400150 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,904 in 195 payments from 15 companies in 2025. Trend: 2023 $2,107 · 2024 $3,644 · 2025 $3,904
Food & beverage: $3,904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 67 | $1,283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 59 | $1,178 |
| Corium, LLC | 22 | $405 |
| Janssen Pharmaceuticals, Inc | 9 | $266 |
| Teva Pharmaceuticals USA, Inc. | 15 | $225 |
| Indivior Inc. | 4 | $107 |
| Gilead Sciences, Inc. | 2 | $77 |
| Lundbeck LLC | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
Products named: CAPLYTA, VRAYLAR, Azstarys, UBRELVY, SPRAVATO, REXULTI, UZEDY, SUBLOCADE.
Industry payments across CT — which companies pay providers there.
